WO2006119598A3 - Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor - Google Patents

Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor Download PDF

Info

Publication number
WO2006119598A3
WO2006119598A3 PCT/BR2006/000090 BR2006000090W WO2006119598A3 WO 2006119598 A3 WO2006119598 A3 WO 2006119598A3 BR 2006000090 W BR2006000090 W BR 2006000090W WO 2006119598 A3 WO2006119598 A3 WO 2006119598A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
device
omega
optionally
combination
fatty acid
Prior art date
Application number
PCT/BR2006/000090
Other languages
French (fr)
Other versions
WO2006119598A2 (en )
Inventor
Jean Marc Millet
Original Assignee
Jean Marc Millet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Abstract

Device for slow liberation via transdermal process of a medicine for reducing an excess of cholesterol and method of production of a transdermic device, which is characterized by a bi-laminate device comprising a flexible macromolecular matrix (2) providing a thickness from 0,15 to 0,6 cm and a surface from 10 to 100 square cm and a posterior coating (1) on one side which allows a considerable reduction (more than 15 times) of the doses to be administered in the treatment of an excess of cholesterol; the macromolecular matrix contains and liberates in a continuous way for a period between 1 to 4 months from 0,05 to 0,18% per day of its total weight of Omega-3 follyocid and / or statin by its surface in contact with the patient's skin without being necessarily the device to be adhered in a fix and permanent way to his / her skin.
PCT/BR2006/000090 2005-05-10 2006-05-10 Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor WO2006119598A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0501708-4 2005-05-10
BRPI0501708 2005-05-10

Publications (2)

Publication Number Publication Date
WO2006119598A2 true WO2006119598A2 (en) 2006-11-16
WO2006119598A3 true true WO2006119598A3 (en) 2007-03-01

Family

ID=37396906

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2006/000090 WO2006119598A3 (en) 2005-05-10 2006-05-10 Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor

Country Status (1)

Country Link
WO (1) WO2006119598A3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940116B1 (en) * 2008-12-22 2012-07-06 Philippe Perovitch Formulation for administration of lipid-lowering oral transmucosal route
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
US9308190B2 (en) 2011-06-06 2016-04-12 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325130A1 (en) * 1983-06-29 1985-01-03 Dick P R Pharmaceutical composition for application to the skin on the basis of essential fatty acids and containing the same device
EP0965340A1 (en) * 1996-12-23 1999-12-22 Nippon Suisan Kaisha, Ltd. Dermatologic preparation
WO2002038196A2 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Plaster with skincare substances

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325130A1 (en) * 1983-06-29 1985-01-03 Dick P R Pharmaceutical composition for application to the skin on the basis of essential fatty acids and containing the same device
EP0965340A1 (en) * 1996-12-23 1999-12-22 Nippon Suisan Kaisha, Ltd. Dermatologic preparation
WO2002038196A2 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Plaster with skincare substances

Also Published As

Publication number Publication date Type
WO2006119598A2 (en) 2006-11-16 application

Similar Documents

Publication Publication Date Title
Peppas et al. Hydrogels in biology and medicine: from molecular principles to bionanotechnology
Gwaltney 2nd Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase IV.
WO2004006906A3 (en) Methods for the treatment of neoplasms
WO2008093670A1 (en) Fermentation product of grape skin/seed by lactic acid bacteria, and pharmaceutical agent and food utilizing the same
Jones et al. Capsaicin 8% topical patch (Qutenza)—a review of the evidence
Zoellner et al. Posttraumatic Growth and Psychotherapy.
WO2004019863A3 (en) Combination therapy for treatment of fibrotic disorders
Anschel et al. Focally injected adenosine prevents seizures in the rat
Wecker et al. Transdermal selegiline: targeted effects on monoamine oxidases in the brain
WO2003068205A1 (en) Compositions and foods for improving lipid metabolism
US20130296324A1 (en) Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment
Prasher et al. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study
WO2008086794A3 (en) Medical product for treating stenosis of body passages and for preventing threatening restenosis
US20020161323A1 (en) Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
JPS58913A (en) Pharmaceutical preparation for topical application
WO2005027842A3 (en) Combinations of drugs for the treatment of neoplasms
WO2006062748A3 (en) Omega-3 fatty acids and dyslipidemic agent for lipid therapy
WO2005112886A3 (en) Methods and articles for the delivery of therapeutic agents
Quik et al. Nicotine administration reduces striatal MPP+ levels in mice
WO2004056335A3 (en) Delivery device containing venlafaxine and memantine and use method thereof
WO2007074406A2 (en) Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
Del Rosso et al. Comprehensive medical management of rosacea: an interim study report and literature review
Pfeiffer Potential of transdermal drug delivery in Parkinson’s disease
CONTRERAS et al. Type of cell death induced by seven metals in cultured mouse osteoblastic cells
Gilden Treatment of Bell's palsy--the pendulum has swung back to steroids alone.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase in:

Ref country code: DE

NENP Non-entry into the national phase in:

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06721647

Country of ref document: EP

Kind code of ref document: A2